FDA Loosens Restrictions On GSK's Avandia

By Andrew Scurria (November 25, 2013, 5:16 PM EST) -- The U.S. Food and Drug Administration on Monday removed prescribing restrictions on GlaxoSmithKline PLC's onetime blockbuster diabetes medication Avandia, capping a turnaround in the agency's assessment of its cardiovascular risks three years after nearly yanking market approval....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!